Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-016128
Filing Date
2012-03-09
Accepted
2012-03-09 19:02:07
Documents
1
Period of Report
2011-08-22

Document Format Files

Seq Description Document Type Size
1 SCHROEDER FORM 4A rrd338170.html 4/A  
1 SCHROEDER FORM 4A rrd338170.xml 4/A 3279
  Complete submission text file 0001181431-12-016128.txt   4788
Mailing Address EMMES GROUP CONSULTING LLC 92 NATOMA ST.#200 SAN FRANCISCO CA 94105
Business Address
Schroeder Martin (Reporting) CIK: 0001412295 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-53127 | Film No.: 12682121

Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Issuer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 4731 Arrangement of Transportation of Freight & Cargo